Baror: Neuronix Alzheimers Treatment Is Unique

July 31 (Bloomberg) -- Medical CEO Eyal Baror talks about his company's product and the expansion of trials in the U.S. He speaks on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

M&A Challenged by Political Volatility, Uncertainty
36:40 - Kurt Simon, vice chairman of M&A at JPMorgan, discusses how the 2016 presidential election is impacting the M&A market. He speaks on "Bloomberg Markets." (Source: Bloomberg)
  • An Inside Look at the $4.83 Billion Verizon-Yahoo Deal
  • Investors Go as Nintendo Captures Few Pokemon Profits
  • Triggering Article 50: When Will Brexit Talks Begin?